Avanir Pharmaceuticals (AVNR) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts AVNR Hot Sheet
Price: $16.96 --0%
Financial Fact:
Loss from operations: -11.89M
Today's EPS Names:
NLY, CP, RUSHA, More
Financial Fact:
Loss from operations: -11.89M
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
Avanir Pharmaceuticals (NASDAQ: AVNR) reported Q2 EPS of ($0.11), in-line with the analyst estimate of ($0.11). Revenue for the quarter came in at $10.1 million versus the consensus estimate of $10.29 million.
For earnings history and earnings-related data on Avanir Pharmaceuticals (AVNR) click here.
For earnings history and earnings-related data on Avanir Pharmaceuticals (AVNR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
- Amerant Bancorp Inc. (AMTB) Misses Q1 EPS by 5c
- Northrim BanCorp (NRIM) Tops Q1 EPS by 54c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
